tiprankstipranks
Trending News
More News >
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (HK:9989)
:9989
Hong Kong Market
Advertisement

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (9989) Ratios

Compare
1 Followers

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H Ratios

HK:9989's free cash flow for Q2 2025 was ¥0.35. For the 2025 fiscal year, HK:9989's free cash flow was decreased by ¥ and operating cash flow was ¥0.23. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
2.29 2.13 2.22 2.25 2.53
Quick Ratio
1.17 0.79 0.99 1.27 1.65
Cash Ratio
0.52 0.37 0.38 0.61 0.75
Solvency Ratio
0.09 -0.06 0.12 0.07 0.18
Operating Cash Flow Ratio
0.42 0.08 -0.14 >-0.01 0.01
Short-Term Operating Cash Flow Coverage
0.97 0.21 -0.32 >-0.01 0.02
Net Current Asset Value
¥ 4.49B¥ 3.39B¥ 3.98B¥ 3.18B¥ 1.79B
Leverage Ratios
Debt-to-Assets Ratio
0.14 0.20 0.31 0.30 0.30
Debt-to-Equity Ratio
0.19 0.32 0.53 0.50 0.49
Debt-to-Capital Ratio
0.16 0.24 0.34 0.33 0.33
Long-Term Debt-to-Capital Ratio
0.04 0.13 0.16 0.16 0.21
Financial Leverage Ratio
1.42 1.61 1.69 1.67 1.64
Debt Service Coverage Ratio
0.25 -0.10 0.48 0.35 0.75
Interest Coverage Ratio
4.35 -1.07 4.83 3.83 5.37
Debt to Market Cap
0.14 0.78 0.68 0.43 0.37
Interest Debt Per Share
1.68 2.73 4.57 3.99 4.35
Net Debt to EBITDA
0.36 -5.82 3.15 3.73 1.56
Profitability Margins
Gross Profit Margin
31.29%33.06%32.61%31.94%39.16%
EBIT Margin
10.34%-12.95%14.88%6.66%29.55%
EBITDA Margin
10.34%-6.09%19.17%11.42%35.25%
Operating Profit Margin
8.41%-4.37%15.86%12.15%24.94%
Pretax Profit Margin
8.41%-17.05%11.59%3.49%24.90%
Net Profit Margin
7.70%-14.38%10.16%3.78%19.21%
Continuous Operations Profit Margin
7.29%-14.73%9.99%3.67%19.16%
Net Income Per EBT
91.56%84.37%87.66%108.33%77.13%
EBT Per EBIT
100.00%389.87%73.11%28.75%99.84%
Return on Assets (ROA)
2.35%-4.08%3.49%1.26%5.38%
Return on Equity (ROE)
3.32%-6.57%5.91%2.11%8.85%
Return on Capital Employed (ROCE)
3.38%-1.67%7.45%5.40%8.63%
Return on Invested Capital (ROIC)
2.58%-1.28%5.55%5.01%5.92%
Return on Tangible Assets
2.79%-4.78%4.07%1.47%6.33%
Earnings Yield
2.16%-16.46%10.28%2.48%7.58%
Efficiency Ratios
Receivables Turnover
3.51 7.27 4.07 4.12 3.15
Payables Turnover
9.91 12.06 11.29 11.23 13.56
Inventory Turnover
0.77 0.55 0.71 0.92 1.02
Fixed Asset Turnover
2.03 2.07 2.89 2.51 2.07
Asset Turnover
0.31 0.28 0.34 0.33 0.28
Working Capital Turnover Ratio
0.93 0.88 1.12 1.11 1.63
Cash Conversion Cycle
538.68 686.23 575.16 452.63 445.50
Days of Sales Outstanding
103.93 50.22 89.77 88.51 115.97
Days of Inventory Outstanding
471.59 666.27 517.72 396.63 356.45
Days of Payables Outstanding
36.83 30.26 32.33 32.50 26.91
Operating Cycle
575.52 716.50 607.49 485.14 472.42
Cash Flow Ratios
Operating Cash Flow Per Share
1.19 0.27 -0.52 >-0.01 0.03
Free Cash Flow Per Share
1.33 -0.03 -0.67 -0.14 -0.13
CapEx Per Share
0.13 0.30 0.15 0.13 0.16
Free Cash Flow to Operating Cash Flow
1.12 -0.12 1.29 30.24 -4.70
Dividend Paid and CapEx Coverage Ratio
5.65 0.46 -1.60 -0.01 0.06
Capital Expenditure Coverage Ratio
8.88 0.90 -3.40 -0.03 0.18
Operating Cash Flow Coverage Ratio
0.74 0.11 -0.12 >-0.01 <0.01
Operating Cash Flow to Sales Ratio
0.33 0.07 -0.11 >-0.01 <0.01
Free Cash Flow Yield
11.41%-0.98%-13.84%-2.06%-1.30%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
46.24 -6.08 9.72 40.40 13.18
Price-to-Sales (P/S) Ratio
3.25 0.87 0.99 1.53 2.53
Price-to-Book (P/B) Ratio
1.54 0.40 0.57 0.85 1.17
Price-to-Free Cash Flow (P/FCF) Ratio
8.76 -102.01 -7.23 -48.52 -77.07
Price-to-Operating Cash Flow Ratio
10.74 11.95 -9.35 -1.47K 362.18
Price-to-Earnings Growth (PEG) Ratio
-0.59 0.03 0.05 -0.51 -1.25
Price-to-Fair Value
1.54 0.40 0.57 0.85 1.17
Enterprise Value Multiple
31.77 -20.18 8.30 17.12 8.74
Enterprise Value
17.28B 6.69B 11.40B 12.44B 16.44B
EV to EBITDA
31.77 -20.18 8.30 17.12 8.74
EV to Sales
3.28 1.23 1.59 1.95 3.08
EV to Free Cash Flow
8.86 -143.36 -11.64 -62.03 -93.81
EV to Operating Cash Flow
9.91 16.80 -15.07 -1.88K 440.84
Tangible Book Value Per Share
6.47 6.25 6.46 5.99 6.54
Shareholders’ Equity Per Share
8.29 8.12 8.39 7.78 8.55
Tax and Other Ratios
Effective Tax Rate
0.13 0.14 0.14 -0.05 0.23
Revenue Per Share
3.59 3.71 4.88 4.34 3.94
Net Income Per Share
0.28 -0.53 0.50 0.16 0.76
Tax Burden
0.92 0.84 0.88 1.08 0.77
Interest Burden
0.81 1.32 0.78 0.52 0.84
Research & Development to Revenue
0.04 0.03 0.04 0.03 0.03
SG&A to Revenue
0.02 0.03 0.02 0.02 0.03
Stock-Based Compensation to Revenue
0.00 0.00 0.00 <0.01 <0.01
Income Quality
14.98 -0.50 -1.06 -0.03 0.04
Currency in CNY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis